BACKGROUND-AIMS: The SOLE study was conducted on a large cohort of Italian patients with moderate-severe Crohn's disease (CD) to assess epidemiological and disease characteristics and their correlation with disease-related worries, treatment satisfaction and adherence, workability. METHODS: The following tools were used over 12 months to assess: Results were correlated with demographic and clinical variables with linear regression models. RESULTS: 552 patients with active CD (51% men) were recruited. Higher worries were having an ostomy bag and undergoing surgery. Variables associated with a higher RFIPC score included female sex, higher disease activity, lower treatment adherence (p\u202f<\u202f0.001), previous surgical treatments (p...
Introduction: Crohn’s disease (CD) is a transmural, typically granulomatous intestinal inflammation...
BACKGROUND: In recent years several trials have addressed treatment challenges in Crohn's disease. C...
Epidemiological profile of 175 patients with Crohn’s disease submitted to biological therapy. J Colo...
Background-Aims: The SOLE study was conducted on a large cohort of Italian patients with moderatesev...
INTRODUCTION: Benefits of immunosuppressive therapy in Crohn's disease have been demonstrated in con...
Background: Crohn’s disease (CD) is a chronic and progressive disease that changes its behaviour ove...
INTRODUCTION: There is currently an increasing use of biological agents in the management of Crohn's...
Background: Incidence and prevalence of Crohn's disease (CD) have increased during the last decades ...
International audienceBackground: Crohn's disease (CD) is a chronic disorder requiring long-term tre...
Background: Crohn's disease (CD) is a chronic immune-mediated inflammatory disease of the gastrointe...
BACKGROUND: Given the heterogeneous nature of Crohn's disease (CD), our aim was to apply the Montrea...
BACKGROUND: This was a prospective observational study designed to evaluate direct and indirect cost...
International audienceBackground: The identification of early prognostic factors during Crohn's dise...
OBJECTIVES: Medical therapy for Crohn's disease (CD) has changed significantly over the past 20 yea...
International audienceObjective The Epi-IBD cohort is a prospective population-based inception cohor...
Introduction: Crohn’s disease (CD) is a transmural, typically granulomatous intestinal inflammation...
BACKGROUND: In recent years several trials have addressed treatment challenges in Crohn's disease. C...
Epidemiological profile of 175 patients with Crohn’s disease submitted to biological therapy. J Colo...
Background-Aims: The SOLE study was conducted on a large cohort of Italian patients with moderatesev...
INTRODUCTION: Benefits of immunosuppressive therapy in Crohn's disease have been demonstrated in con...
Background: Crohn’s disease (CD) is a chronic and progressive disease that changes its behaviour ove...
INTRODUCTION: There is currently an increasing use of biological agents in the management of Crohn's...
Background: Incidence and prevalence of Crohn's disease (CD) have increased during the last decades ...
International audienceBackground: Crohn's disease (CD) is a chronic disorder requiring long-term tre...
Background: Crohn's disease (CD) is a chronic immune-mediated inflammatory disease of the gastrointe...
BACKGROUND: Given the heterogeneous nature of Crohn's disease (CD), our aim was to apply the Montrea...
BACKGROUND: This was a prospective observational study designed to evaluate direct and indirect cost...
International audienceBackground: The identification of early prognostic factors during Crohn's dise...
OBJECTIVES: Medical therapy for Crohn's disease (CD) has changed significantly over the past 20 yea...
International audienceObjective The Epi-IBD cohort is a prospective population-based inception cohor...
Introduction: Crohn’s disease (CD) is a transmural, typically granulomatous intestinal inflammation...
BACKGROUND: In recent years several trials have addressed treatment challenges in Crohn's disease. C...
Epidemiological profile of 175 patients with Crohn’s disease submitted to biological therapy. J Colo...